BRIEF published on 10/05/2026 at 15:55, 2 hours 27 minutes ago EpiSign and Geneyx Unite for Genomic and Epigenomic Advances in Rare Diseases Partnership Sequencing Technology Genomic Analysis Epigenomic Insights Rare Disease Diagnosis
PRESS RELEASE published on 10/05/2026 at 15:50, 2 hours 32 minutes ago EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease EpiSign and Geneyx partner to integrate genomic and epigenomic analysis for rare diseases, combining expertise in DNA methylation with multi-omics capabilities Rare Disease Genomic EpiSign Geneyx Epigenomic
Published on 10/05/2026 at 14:45, 3 hours 37 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 3 hours 52 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 3 hours 52 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 4 hours 22 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 4 hours 22 minutes ago GameSquare to Present at Upcoming Investor Conferences
Published on 10/05/2026 at 18:00, 22 minutes ago 2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of September 30, 2026
Published on 10/05/2026 at 17:45, 37 minutes ago BILENDI: Bilendi unveils major evolution for BARI AI in its Bilendi Discuss platform
Published on 10/05/2026 at 17:07, 1 hour 14 minutes ago Amprion successfully issues more green bonds worth EUR 1.5 billion
Published on 10/05/2026 at 15:50, 2 hours 32 minutes ago EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
Published on 10/05/2026 at 15:49, 2 hours 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior PLC
Published on 10/05/2026 at 18:13, 9 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 17:45, 37 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 10/05/2026 at 17:45, 37 minutes ago Declaration of voting rights at the end of September 2026
